Article Text

Download PDFPDF
Introduction
  1. John R Hughes
  1. University of Vermont Human Behavioral Pharmacology Laboratory, Burlington, Vermont, USA

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Our next presenters will be discussing several of the implications of the different kinds of harm reduction. Then we shall have the reactions of our panelists. Let me introduce our presenters and panelists.

Our first presenter is Neal L Benowitz who is going to talk about medical implications of harm reduction. Dr Benowitz is professor of medicine, psychiatry, and pharmacology and chief of the division of clinical pharmacology and experimental therapeutics at the University of California-San Francisco. His research has focused primarily on human pharmacology and toxicology of nicotine.

Our next speaker is Judith …

View Full Text